{"text": "rt AT_USER $amgn down after hours but the chart master says you should buy the dip URL"}
{"text": "$amgn post-close ..4052k shares URL"}
{"text": "what's behind amgen's q3 revenue decline URL $amgn"}
{"text": "$amgn latest headlines URL"}
{"text": "amgen inc. 2017 q3 - results - earnings call slides $amgn URL"}
{"text": "why amgn is down in after hours trading amgen earnings results - trade unusual option activity profitably URL $amgn"}
{"text": "beat the market with the ideal intensity indicator, the only indicator you need $bwld $srpt $amgn $uctt\u00a1\u00ad URL"}
{"text": "amgen inc. $amgn issues fy17 earnings guidance URL"}
{"text": "amgen inc. $amgn issues fy17 earnings guidance URL"}
{"text": "amgen inc. $amgn issues fy17 earnings guidance URL #acn"}
{"text": "amgen inc. $amgn issues fy17 earnings guidance URL"}
{"text": "amgen inc. $amgn issues fy17 earnings guidance URL"}
{"text": "members get free tools to manage emotions, reduce randomness, and risk mgt $amgn $uctt $bwld $srpt\u00a1\u00ad URL"}
{"text": "$amgn - amgen inc. #amgn issues fy17 earnings guidance URL"}
{"text": "rt AT_USER asked about car-t, $amgn sean harper says they continue to support their $kite partnership, but are sticking to focusing on\u00a1\u00ad"}
{"text": "rt AT_USER $amgn discontinuing cetp inhibitor program. that's it for the cetps. more on earnings on AT_USER"}
{"text": "unicorn bay rating for $amgn is 2.83 out of 5. URL"}
{"text": "rt AT_USER $amgn talking about high enthusiasm among physicians at international headache society conference for cgrp inhibitors in mi\u00a1\u00ad"}
{"text": "rt AT_USER \"cell-based therapies do have a role\" &amp; we're tracking very closely, $amgn's harper says. but next 3-5 yrs focus is bispeci\u00a1\u00ad"}
{"text": "rt AT_USER $amgn r&amp;d head says bispecific approach \"very powerful technology,\" off-the-shelf vs car-t, ben/risk profile could lead to\u00a1\u00ad"}
{"text": "wondering about risks of $amgn? the 21-day volatility is 3.67% URL"}
{"text": "rt AT_USER \"cell-based therapies do have a role\" &amp; we're tracking very closely, $amgn's harper says. but next 3-5 yrs focus is bispeci\u00a1\u00ad"}
{"text": "AT_USER that was $amgn's opinion about car-t\u00a1\u00aanot necessarily my own."}
{"text": "rt AT_USER $amgn r&amp;d head says bispecific approach \"very powerful technology,\" off-the-shelf vs car-t, ben/risk profile could lead to\u00a1\u00ad"}
{"text": "stop trading randomly, get the best opportunities and profit everyday $bwld $srpt $amgn $uctt\u00a1\u00ad URL"}
{"text": "rt AT_USER $amgn r&amp;d head says bispecific approach \"very powerful technology,\" off-the-shelf vs car-t, ben/risk profile could lead to\u00a1\u00ad"}
{"text": "rt AT_USER \"cell-based therapies do have a role\" &amp; we're tracking very closely, $amgn's harper says. but next 3-5 yrs focus is bispeci\u00a1\u00ad"}
{"text": "AT_USER $amgn harper says continuing to work with $kite now $gild &amp; continuing to look at cell tx, but more foc\u00a1\u00ad URL"}
{"text": "cell-based therapies do have a role\" &amp; we're tracking very closely, $amgn's harper says. but next 3-5 yrs focus is bispecifics"}
{"text": "asked about car-t, $amgn sean harper says they continue to support their $kite partnership, but are sticking to focusing on bites."}
{"text": "price moves vs expected moves $esrx $bmy $gild $pfe $vrx $celg $thc $mrk $srpt $agn $amgn $teva\u00a1\u00ad URL"}
{"text": "$amgn r&amp;d head says bispecific approach \"very powerful technology,\" off-the-shelf vs car-t, ben/risk profile could lead to earlier treatment"}
{"text": "rt AT_USER \"we're humbled and incredibly proud\" of staff in puerto rico, $amgn ceo says"}
{"text": "we're humbled and incredibly proud\" of staff in puerto rico, $amgn ceo says"}
{"text": "AT_USER $amgn is one of my favorite biotech buys, i like the company's business model &amp; robust management. p\u00a1\u00ad URL"}
{"text": "$amgn: amgen beats by $0.17, reports revs in-line; raises low-end of fy17 eps, revs guidance URL"}
{"text": "$amgn down after hours but the chart master says you should buy the dip URL"}
{"text": "access tools built by 10% traders for 10% traders $srpt $uvxy $bwld $amgn URL URL"}
{"text": "$amgn talking about high enthusiasm among physicians at international headache society conference for cgrp inhibitors in migraine"}
{"text": "AT_USER AT_USER carter worth likes $amgn"}
{"text": "$amgn ceo bob bradway response: we are happy with our $nvs cns partnership. we are building up our (standalone) cv franchise."}
{"text": "on $amgn call, umer raffat asks if amgen considered extending $nvs cns partnership to cv, considering novartis\u00a1\u00afs growing portfolio."}
{"text": "amgen #earnings tonight. get numbers into model AT_USER hurricane impact at pr facility est. 15-18 cps $amgn\u00a1\u00ad URL"}
{"text": "after hours  decliners $uctt $ntri $wpz $now $var $orly $ntgr $mlnx $ctxs $dlb $ctrl $uvxy $tvix $wday $trn $amgn URL"}
{"text": "rt AT_USER $amgn discontinuing cetp inhibitor program. that's it for the cetps. more on earnings on AT_USER"}
{"text": "big call buyers URL $sfly $auy $momo $apc $amgn $bac $omer $regn $bk $rrc $cog $shop $orly $bud $fit $azn $gogo $mmm"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "rt AT_USER prolia (denosumab) sales increased 22% with 19% volume growth year over year in q3\u00a1\u00af17 $amgn URL"}
{"text": "prolia (denosumab) sales increased 22% with 19% volume growth year over year in q3\u00a1\u00af17 $amgn URL"}
{"text": "rt AT_USER $amgn \u00a1\u00ae17 q3 earnings: we are focused on a strong finish to \u00a1\u00ae17 as we prepare launches for \u00a1\u00af18 URL"}
{"text": "11 stocks moving in wednesday's after-hours session URL $bwld $srpt $lvs $tsco $amgn $ffiv $now $ctxs $xlnx $uctt $orly"}
{"text": "rt AT_USER amgen incurred $66m in pre-tax expenses related to hurricane maria; expect $75-100m total and at least 8 cents per share hit\u00a1\u00ad"}
{"text": "AT_USER AT_USER i like cbw's charting...grabbed $amgn after hrs at 172.50. i'll take that pullback any day!"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "$amgn \u00a1\u00ae17 q3 earnings: we are focused on a strong finish to \u00a1\u00ae17 as we prepare launches for \u00a1\u00af18 URL"}
{"text": "$amgn, $bwld, $srpt, $lvs 11 stocks moving in wednesday's after-hours session - URL"}
{"text": "rt AT_USER listen: senior research analyst AT_USER  on AT_USER  discussing earnings of $amgn, $celg and preview of\u00a1\u00ad"}
{"text": "amgen raises full-year guidance URL $amgn #pharma"}
{"text": "rt AT_USER new post:  stock market recap 10/25/17 {video} URL $amgn $irbt $qqq $spy $uvxy"}
{"text": "the stock market is always ready, are you? $uvxy $bwld $amgn $tvix URL URL"}
{"text": "new post:  stock market recap 10/25/17 {video} URL $amgn $irbt $qqq $spy $uvxy"}
{"text": "AT_USER come on guys, last week $amgn was said to be a technical buy. another technical buy today with different technical approach?"}
{"text": "rt AT_USER $amgn finally joins the crowd and discontinues cetp inhibitor. finally."}
{"text": "$amgn needs to hold recent lows at 166"}
{"text": "rt AT_USER amgen incurred $66m in pre-tax expenses related to hurricane maria; expect $75-100m total and at least 8 cents per share hit\u00a1\u00ad"}
{"text": "amgen incurred $66m in pre-tax expenses related to hurricane maria; expect $75-100m total and at least 8 cents per share hit $amgn"}
{"text": "amgen inc. updates fy17 guidance to $12.50-12.70 eps &amp; revenue guidance to $22.7-23 billion.  URL $amgn #amgn"}
{"text": "10 healthcare stocks to buy for a dividend lifeline URL $abbv $mrk $jnj $nvo $cah $ohi $amgn $pfe $cvs $gsk"}
{"text": "prolia (denosumab), repatha (evolocumab), kyprolis (carfilzomib) and blincyto (blinatumomab) exhibited solid volume growth in q3\u00a1\u00af17 $amgn"}
{"text": "rt AT_USER $amgn cetp inhibitor development (unsurprisingly) discontinued; couple of phase i updated, including three bites. URL"}
{"text": "drug sales disappoint at amgen $amgn URL"}
{"text": "rt AT_USER drug sales disappoint at amgen URL $amgn"}
{"text": "#options #maxpain chart for $amgn. free options app URL URL"}
{"text": "rt AT_USER $amgn discontinuing cetp inhibitor program. that's it for the cetps. more on earnings on AT_USER"}
{"text": "amgen reports revenues of $5.77 billion in q3 $amgn URL"}
{"text": "biotech still in selloff mode, $amgn $vrtx both down after er.  other ers are mostly down as well, $orly $xlnx $ctxs."}
{"text": "rt AT_USER price of #fomo in drug development: $amgn takes charge for discontinuing a cetp inhibitor no one was expecting, 11 yrs after\u00a1\u00ad"}
{"text": "when will $amgn actually start finding a new pipeline, rather than sending their patent lawyers over to $regn to tr\u00a1\u00ad URL"}
{"text": "rt AT_USER listen: senior research analyst AT_USER on AT_USER discussing earnings of $amgn, $celg and preview of $gild 4:45\u00a1\u00ad"}
{"text": "$amgn cetp inhibitor development (unsurprisingly) discontinued; couple of phase i updated, including three bites. URL"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "$amgn listen to q3 2017 amgen inc. earnings call live at 05:00 pm, ondemand after - URL"}
{"text": "drug sales disappoint at amgen URL $amgn"}
{"text": "drug sales disappoint at amgen URL $amgn"}
{"text": "$amgn shares down 2.5% post-market URL"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "listen live at 2pm pt: #amgen q3 2017 earnings webcast: URL  $amgn"}
{"text": "$amgn #options oi chart. free stocks app URL URL"}
{"text": "AT_USER what do you do if you're holding your entire account in $amgn... asking for a friend URL"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "rt AT_USER \"dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "as amgen  $amgn share value declined, baring asset management ltd lowered by $827,492 its stake ..."}
{"text": "$amgn not helping bios AT_USER"}
{"text": "dismal repatha growth\" laments kennen mackay at rbc. ($89m vs est of $105.6m) $amgn"}
{"text": "listen: senior research analyst AT_USER  on AT_USER  discussing earnings of $amgn, $celg and preview of $gild 4:45 pm edt"}
{"text": "rt AT_USER listen: senior research analyst AT_USER on AT_USER discussing earnings of $amgn, $celg and preview of $gild 4:45\u00a1\u00ad"}
{"text": "rt AT_USER $amgn discontinuing cetp inhibitor program. that's it for the cetps. more on earnings on AT_USER"}
{"text": "rt AT_USER price of #fomo in drug development: $amgn takes charge for discontinuing a cetp inhibitor no one was expecting, 11 yrs after\u00a1\u00ad"}
{"text": "rt AT_USER listen: senior research analyst AT_USER on AT_USER discussing earnings of $amgn, $celg and preview of $gild 4:45\u00a1\u00ad"}
{"text": "$amgn slides on er.. $labd $labu $xbi algos will continue to attack bios until they capitulate everyone out &amp; then reverse. #gameofwallst"}
